PMSA Board of Directors

The current PMSA Board members are listed below. They welcome your questions and feedback. You may also contact PMSA headquarters page.

President:
Jin Tong
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Novartis
     Vice President:
Karthikeyan Chidambaram
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Genentech, Inc.
650.225.4620
 
Treasurer/Secretary:
Vishal Chaudhary
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Sanofi
302.468.9275
     Professional Development Chair:
Nuray Yurt
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Novartis
867.778.9613
 
Marketing Committee Chair:
Haibei Jiang
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Bayer Pharmaceuticals
862.404.6131
  Research & Education Chair:
Igor Rudychev
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
AstraZeneca
 
Program Committee Chair:
Arlene Little
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Genentech, Inc.





     Program Committee:
Nathan Wang
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Janssen Pharmaceuticals, Inc.
Program Committee:
Mehul Shah
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Sanofi
    
 
Executive Advisory Council:
David Purdie
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Genentech, Inc.
650.467.2637
     Executive Advisory Council:
Cynthia Dilley
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
UCB, Inc.
770.970.8565
 
Executive Advisory Council:
Jason Carlin
email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Novartis
973.305.6180